D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Price:
20 750
KRW
14.64%
Market Closed
Market Cap:
₩938.5B
Balance Sheet
Balance Sheet Decomposition
Dongkook Pharmaceutical Co Ltd
Dongkook Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
Dongkook Pharmaceutical Co Ltd
Dongkook Pharmaceutical Co Ltd
Balance Sheet
Dongkook Pharmaceutical Co Ltd
Dongkook Pharmaceutical Co Ltd
Currency: KRW
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
13 443
|
26 414
|
37 033
|
56 363
|
63 132
|
61 802
|
70 260
|
54 537
|
85 444
|
73 693
|
60 552
|
50 272
|
|
| Cash Equivalents |
13 443
|
26 414
|
37 033
|
56 363
|
63 132
|
61 802
|
70 260
|
54 537
|
85 444
|
73 693
|
60 552
|
50 272
|
|
| Short-Term Investments |
22 266
|
22 889
|
26 486
|
32 763
|
39 248
|
54 611
|
82 033
|
119 649
|
83 486
|
30 261
|
33 158
|
38 432
|
|
| Total Receivables |
81 449
|
88 551
|
95 599
|
95 256
|
111 827
|
114 177
|
117 115
|
136 983
|
139 496
|
151 600
|
179 061
|
209 391
|
|
| Accounts Receivables |
80 670
|
81 997
|
87 790
|
88 180
|
102 428
|
101 677
|
105 734
|
123 489
|
124 926
|
134 407
|
162 003
|
181 830
|
|
| Other Receivables |
779
|
6 554
|
7 809
|
7 076
|
9 399
|
12 500
|
11 381
|
13 494
|
14 570
|
17 193
|
17 057
|
27 561
|
|
| Inventory |
32 635
|
31 467
|
32 522
|
45 243
|
50 703
|
63 511
|
60 867
|
79 048
|
102 591
|
120 152
|
138 343
|
159 577
|
|
| Other Current Assets |
2 827
|
3 842
|
3 539
|
4 368
|
6 276
|
6 327
|
8 747
|
8 545
|
9 210
|
9 615
|
8 083
|
12 334
|
|
| Total Current Assets |
152 620
|
173 164
|
195 179
|
233 994
|
271 186
|
300 428
|
339 022
|
398 763
|
420 226
|
385 321
|
419 197
|
470 007
|
|
| PP&E Net |
44 362
|
53 398
|
56 936
|
62 788
|
69 428
|
140 740
|
158 074
|
194 967
|
234 941
|
263 355
|
272 705
|
299 459
|
|
| PP&E Gross |
44 362
|
53 398
|
56 936
|
62 788
|
69 428
|
140 740
|
158 074
|
194 967
|
234 941
|
263 355
|
272 705
|
299 459
|
|
| Accumulated Depreciation |
46 946
|
50 735
|
56 112
|
59 071
|
80 083
|
87 570
|
99 851
|
114 076
|
127 464
|
143 986
|
162 292
|
197 609
|
|
| Intangible Assets |
4 273
|
3 971
|
4 197
|
4 230
|
4 326
|
4 359
|
4 244
|
7 299
|
6 916
|
10 873
|
16 162
|
30 328
|
|
| Goodwill |
1 328
|
1 053
|
1 053
|
1 053
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12 172
|
|
| Note Receivable |
0
|
100
|
100
|
2 159
|
2 094
|
2 094
|
638
|
6 000
|
6 006
|
6 003
|
6 003
|
0
|
|
| Long-Term Investments |
12 660
|
8 884
|
13 130
|
15 711
|
21 462
|
28 515
|
36 360
|
48 242
|
72 219
|
88 735
|
112 636
|
130 665
|
|
| Other Long-Term Assets |
3 013
|
3 597
|
4 203
|
5 163
|
4 812
|
4 109
|
6 045
|
7 893
|
9 768
|
14 042
|
12 832
|
10 535
|
|
| Other Assets |
1 328
|
1 053
|
1 053
|
1 053
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12 172
|
|
| Total Assets |
218 257
N/A
|
244 166
+12%
|
274 799
+13%
|
325 098
+18%
|
373 308
+15%
|
480 245
+29%
|
544 384
+13%
|
663 165
+22%
|
750 076
+13%
|
768 330
+2%
|
839 535
+9%
|
953 165
+14%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
14 124
|
17 141
|
18 108
|
21 048
|
20 263
|
18 056
|
17 057
|
26 523
|
29 171
|
33 405
|
62 069
|
80 351
|
|
| Accrued Liabilities |
3 121
|
3 392
|
3 884
|
3 471
|
4 330
|
4 046
|
4 776
|
5 264
|
6 071
|
5 957
|
6 877
|
8 496
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
15 166
|
15 018
|
13 854
|
82 191
|
36 954
|
48 228
|
46 744
|
|
| Current Portion of Long-Term Debt |
2 912
|
4 492
|
6 963
|
5 136
|
9 515
|
0
|
2 070
|
22 486
|
24 375
|
26 979
|
36 300
|
5 316
|
|
| Other Current Liabilities |
23 572
|
27 748
|
29 879
|
43 233
|
46 074
|
55 099
|
71 089
|
96 768
|
100 793
|
95 243
|
77 679
|
91 785
|
|
| Total Current Liabilities |
43 728
|
52 773
|
58 834
|
72 888
|
80 182
|
92 367
|
110 011
|
164 895
|
242 601
|
198 539
|
231 153
|
232 692
|
|
| Long-Term Debt |
700
|
1 603
|
1 485
|
482
|
360
|
40 120
|
43 199
|
52 115
|
13 687
|
27 449
|
20 219
|
28 627
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3 288
|
5 765
|
4 806
|
4 846
|
6 505
|
|
| Minority Interest |
357
|
256
|
998
|
1 022
|
15 556
|
18 589
|
22 545
|
24 438
|
27 079
|
29 125
|
31 480
|
75 499
|
|
| Other Liabilities |
11 589
|
13 226
|
13 866
|
13 391
|
13 271
|
16 146
|
5 754
|
7 061
|
6 378
|
6 471
|
7 144
|
6 364
|
|
| Total Liabilities |
56 375
N/A
|
67 857
+20%
|
75 182
+11%
|
87 783
+17%
|
109 369
+25%
|
167 222
+53%
|
181 509
+9%
|
251 797
+39%
|
295 510
+17%
|
266 391
-10%
|
294 841
+11%
|
349 688
+19%
|
|
| Equity | |||||||||||||
| Common Stock |
22 230
|
22 230
|
22 230
|
22 230
|
22 230
|
22 615
|
22 615
|
22 615
|
22 615
|
22 615
|
22 615
|
22 615
|
|
| Retained Earnings |
125 169
|
142 923
|
166 385
|
203 892
|
239 583
|
278 409
|
328 380
|
376 729
|
419 761
|
467 179
|
507 318
|
558 208
|
|
| Additional Paid In Capital |
12 057
|
12 057
|
12 057
|
12 057
|
3 286
|
13 022
|
12 903
|
13 047
|
13 213
|
13 042
|
15 566
|
23 372
|
|
| Unrealized Security Profit/Loss |
1 354
|
854
|
838
|
1 029
|
733
|
870
|
870
|
870
|
870
|
870
|
870
|
870
|
|
| Treasury Stock |
174
|
3 000
|
3 138
|
3 138
|
3 138
|
3 138
|
3 138
|
3 138
|
3 138
|
3 095
|
3 053
|
3 016
|
|
| Other Equity |
1 245
|
1 245
|
1 245
|
1 245
|
1 245
|
1 245
|
1 245
|
1 245
|
1 245
|
1 329
|
1 379
|
1 427
|
|
| Total Equity |
161 881
N/A
|
176 309
+9%
|
199 617
+13%
|
237 315
+19%
|
263 939
+11%
|
313 023
+19%
|
362 874
+16%
|
411 368
+13%
|
454 566
+11%
|
501 939
+10%
|
544 694
+9%
|
603 477
+11%
|
|
| Total Liabilities & Equity |
218 257
N/A
|
244 166
+12%
|
274 799
+13%
|
325 098
+18%
|
373 308
+15%
|
480 245
+29%
|
544 384
+13%
|
663 165
+22%
|
750 076
+13%
|
768 330
+2%
|
839 535
+9%
|
953 165
+14%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
44
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
